Long Term Results of Ulnar Shortening Osteotomy for Ulnar Impaction Syndrome

April 19, 2011

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Michelle G. Carlson, MD

Co-Investigators

Andrew J Weiland, MD
Richard H Gelberman, MD
Ryan P Calfee, MD
Duretti Fufa, MD

Summary

This study intends to evaluate long-term outcomes of ulnar shortening osteotomy for Ulnar Impaction Syndrome.  Via phone survey we are collecting post-surgical arm function, symptoms, and patient satisfaction data.

Inclusion/Exclusion Criteria

Participants be 18 or older, and must have undergone ulnar shortening Osteotomy with the principal investigator or one of the co-investigators to be eligible for study participation

Contact Information

Michelle G. Carlson, MD
carlsonm@hss.edu
 212.774.2727